Hotaling Investment Management »

Halozyme Therapeutics shares owned by Hotaling Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Hotaling Investment Management from 13F filings

Historical chart of Hotaling Investment Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Hotaling Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Hotaling Investment Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $250k 4.4k 56.84

More positions owned by Hotaling Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
UnitedHealth (UNH)
Amazon (AMZN)
Nextera Energy (NEE)
BlackRock (BLK)
Pepsi (PEP)
Deere & Company (DE)
MetLife (MET)
Cummins (CMI)
Marriott Intl Cl A (MAR)
Visa Com Cl A (V)
Abbvie (ABBV)

View all positions for Hotaling Investment Management

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics